Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model
Authors:
- 14 April 2023
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 562, 216169
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In VitroJournal of Cancer, 2012
- CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survivalJournal of Clinical Neuroscience, 2010
- Vaccinia Virus–Encoded Ribonucleotide Reductase Subunits Are Differentially Required for Replication and PathogenesisPLOS Pathogens, 2010
- Intelligent Design: Combination Therapy With Oncolytic VirusesMolecular Therapy, 2010
- Vaccinia virus vaccines: Past, present and futureAntiviral Research, 2009
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatmentBlood, 2009
- Development of a novel mouse glioma model using lentiviral vectorsNature Medicine, 2009
- Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionJournal of Neuro-Oncology, 2007
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007
- An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme1Neuro-Oncology, 2006